France vs Palestine, State of: Protecting minority investors (DB06-14 methodology) - Score
France
53.33
in 2013
Palestine, State of
53.33
in 2013
France rank
83rd
Palestine, State of rank
83rd
Protecting minority investors (DB06-14 methodology) - Score over time
- France
- Palestine, State of
How they compare
France currently reports 53.33 against 53.33 in Palestine, State of, a difference of 0.
Across all 9 years both countries report, Palestine, State of has been ahead every year.
France ranks 83rd and Palestine, State of ranks 83rd of 191 countries.
Head to head by decade
| Decade | France | Palestine, State of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.33 | 53.33 | 0 | — |
| 2010s | 53.33 | 53.33 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors (db06-14 methodology) - score, France or Palestine, State of?
- France, at 53.33 against 53.33 in Palestine, State of as of 2013.
- What is the difference in protecting minority investors (db06-14 methodology) - score between France and Palestine, State of?
- 0, with France ahead.
- How many years of comparable data are there for France and Palestine, State of?
- 9 years are reported by both, from 2005 to 2013.
- How do France and Palestine, State of rank globally for protecting minority investors (db06-14 methodology) - score?
- France ranks 83rd and Palestine, State of ranks 83rd of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for protecting minority investors benchmarks economies with respect to the regulatory best practice on the indicator set. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.